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Abstract 
Human plasma and its fractions/derivatives are frequently used materials in biomedicine 
as it contains thousands and thousands of proteins representing the majority of human 
proteome. Several important methods were developed in the past for the fractionation of 
this important biological fluid and their use for medicinal purposes. One of the greatest 
challenges is the very large dynamic range of plasma proteins ranging up to 10-12 
orders of magnitude. Early attempts were mainly based on methods such as salting out 
or cold ethanol precipitation, as well as chromatography utilizing affinity, size 
exclusion, ion exchange and hydrophobic interaction techniques. More recently, 
fractionation applications started with the depletion of the high abundant plasma 
components, such as serum albumin and immunoglobulins, before isolating lower 
abundant proteins of interest. Plasma volumes were utilized from the milliliter scale for 
diagnostic applications to hundreds of liters for industrial scale plasma fractionation 
(e.g., medicinal product manufacturing). In this paper we review this important part of 
medicinal chemistry, highlighting the traditional methods along with some of their 
variations as well as the most significant recent achievements of the field. 
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1 Introduction 
About 20% of the extracellular fluid in the human body is comprised by plasma, which 
is one of the most studied and processed biological substance in the pharmaceutical 
industry and biomedical sciences. Its exceptional importance is due to the high 
complexity consisting of thousands and thousands of proteins originating from the 
proteomes of practically all body tissues [1]. Millions of liters are fractionated over the 
world annually for isolation and purification of therapeutic products under carefully 
designed, strictly hygienic conditions in accredited plasma fractionation plants, mainly 
based on conventional precipitation and chromatographic techniques [2]. The most 
abundant plasma constituents are human serum albumin (HSA) and the 
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immunoglobulins, representing ~80% of all plasma proteins. HSA is accounted for 
about the half of the therapeutic plasma protein products sold worldwide during the last 
decades and used for treatment of e.g. exsanguination, hypoproteinemia or 
hypoalbuminemia  just to mention a few important ones [3]. In addition, the biomedical 
research also consumes significant amounts of plasma as a source to isolate different 
important plasma components or for biomedical and diagnostic research. For the latter 
one, it is of great importance to remove the highest abundant proteins, especially HSA 
and immunoglobulins since these components are mostly considered to be non-
informative and obscure the ones of diagnostic biomarker potential present in much 
lower abundance. Accordingly precise, sometimes exhaustive and expensive 
preparation/pre-fractionation techniques are needed to deplete the most abundant 
plasma constituents prior to deep proteomic analyses, e.g. with two-dimensional 
electrophoresis or mass spectrometry. The role of traditional precipitation and 
chromatographic methods of size exclusion, ion exchange or hydrophobic interaction - 
frequently arranged in combination for enhanced effectiveness - to fulfill this aim is still 
unquestionable. However, there is a recent spread of affinity-based methods, 
representing a significant portion of sample preparation techniques. These affinity-based 
techniques are able to simultaneously remove the most abundant plasma components 
quickly and easily, with high recovery. In this review, selected examples of the most 
important and widespread methods are described together with recent developments and 
techniques to fractionate the human plasma proteome. 
 
2 Precipitation based methods 
2.1 Salting out with inorganic salts 
About a hundred years ago, the famous German chemist, Franz Hofmeister and his 
coworkers elaborated the salting out method making a contribution of historical 
importance on the effects of inorganic salts on protein precipitation. They used salts 
with mono- and bivalent cations for the treatment of serum and coined the main 
separated fractions as ‘globulins’ (precipitated at lower salt concentrations) and 
‘albumins’ (precipitated at higher salt concentrations).  The original papers were written 
in archaic German but their English translation can be found in [4]. While precipitation 
methods have not changed so much since their introduction, it is of great importance to 
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choose the most suitable buffer (concentration, pH, ionic strength) to achieve the best 
possible reconstitution of the protein precipitate without leaving clumps or aggregates in 
the solution. Although the establishment of the mechanism was developed on serum and 
the first experiments were also performed using serum, the same principles were also 
adapted to plasma precipitation. 
 
2.2 Precipitation with organic solvents 
The Cohn method [5] is considered as affecting the practice of large-scale plasma 
fractionation to the greatest extent. The main goal of this cold ethanol fractionation was 
the production of pure albumin for therapeutic purposes but the immunoglobulins were 
separated too. This technique was easy, effective and aseptic, thus still being used, 
mainly in the U.S. [6]. The original process was further developed by Kistler and 
Nitschman [7] by including multi-step processes. Coagulation factors were removed in 
the form of cryoprecipitate, while plasma was being thawed first followed by fibrinogen 
precipitation with 8% cold ethanol. During the second cold ethanol precipitation step 
(please note that the Cohn method used 25% ethanol at pH 6.9, while the Kistler-
Nitschman method used 19% ethanol at pH 5.85) the immunoglobulins were removed 
and the remaining solution contained the albumin product. HSA was purified from α- 
and β-globulins by the addition of more ethanol (to 40%) in one (Kistler-Nitschman) or 
two steps (Cohn). Final albumin precipitation took place near its isoelectric point at pH 
4.8. In spite of the large ethanol consumption, this latter method is more cost-effective 
thus became more popular in Europe [8]. 
The combination of ethanol and heat treatment of plasma was another labor- and cost-
effective technique resulting in high quality albumin [9]. Another precipitation option 
employed ether, an apolar solvent used for e.g. lipid extraction in the laboratory 
practice, but therewith it was described to be suitable for the fractionation of human 
plasma even for clinical purposes. Using ether precipitation the main plasma proteins, 
albumin and γ-globulin were separated together with fibrinogen and prothrombin. Ether 
concentrations, pH, ionic strength and temperature were well defined and the treatment 
was performed under strict aseptic conditions [10]. 
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2.3 Rivanol precipitation 
Hořejší and Smetana [11] found that Rivanol (2-ethoxy-6,9-diaminacridine lactate), a 
positively charged acridine derivative, precipitated blood plasma proteins. First the 
agent was applied at the concentration of 0.3% and all plasma proteins were precipitated 
except the γ-globulin fraction. The supernatant was collected by centrifugation and 
activated charcoal was used to remove the Rivanol. The resulting 97% pure γ-globulin 
was found to be suitable for clinical use. They have also performed a quantitative study 
on serum precipitation and found that with the increase of the concentration of the 
substance the amounts of the precipitated albumin, α- and β-globulin and also the γ-
globulin were increased. Since the introduction of this method, several important 
plasma proteins were produced by the rivanol precipitation technique and antibodies 
were raised against some of them [1]. 
 
2.4 Polyethylene glycol precipitation 
Polyethylene glycol (PEG) is a water-soluble synthetic polymer, usually used at 
industrial scales to isolate important plasma components [12]. It is considered to be 
non-toxic and chemically relatively inert [13]. Schneider and co-workers combined heat 
fractionation with polyethylene glycol precipitation yielding at least 90% of the original 
albumin content of the plasma [14]. 
 
3 Chromatographic methods 
3.1 Large-scale processing for biomedicine manufacturing 
Besides the widespread laboratory level applications, chromatographic methods were 
developed and utilized for the purification of different plasma proteins for therapeutic 
purposes, since these techniques allow the isolation and purification of high purity 
proteins both in the laboratory and industrial scales. Since most plasma proteins bear 
charges, ion exchange chromatography is a good fractionation tool, frequently coupled 
with other chromatographic methods. Ion exchange can also be used for the elimination 
of proteins of no interest. Affinity ligands are usually used to partition proteins of 
interest as well as to remove impurities from the final product. Size exclusion 
chromatography or gel filtration is another complementary step to a multi-stage 
fractionation process to eliminate contaminants [15]. In this section we discuss selected 
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examples on the application of chromatographic methods for the production scale 
purification of plasma proteins for therapeutic use.  
High purity (>95%) albumin was produced by means of QAE-Sephadex A-50 ion 
exchange resin from the supernatant after the precipitation of immunoglobulins with 
PEG [16]. Another abundant plasma component, immunoglobulin G was separated 
from human plasma cryosupernatant by the combination of several methods such as ion 
exchange chromatography (DEAE-Sepharose), affinity chromatography (arginine 
Sepharose 4B) and size exclusion chromatography (Sephacryl S-300 HR) as the final 
purification tool obtaining a yield of 3.5 g IgG from one liter plasma [17]. 
In a novel approach, anion exchange was the anterior step followed by metal chelate 
affinity chromatography for the manufacture of α-1 antitrypsin (AAT), which protein in 
purified form can possibly cure AAT deficiency when administered intravenously [18]. 
Coagulation factors that are used in the treatments of different hemophilias are also 
usually purified by chromatography. Te Booy et al. combined DEAE-Sephadex A-50 
anion exchange chromatography with affinity chromatography using a special affinity 
matrix dimethylamino-propylcarbamylpentyl-Sepharose CL-4B. The first step separated 
coagulation factors II, IX and X, while factor VIII (also known as anti-hemophilic 
factor) was isolated by the affinity step yielding good recovery and high specific 
activity [19]. 
 
3.2 Laboratory scale applications for biomedical research 
In common laboratory practice, the different plasma proteins are not solely isolated for 
medicinal reasons but rather for other kind of research use, e.g. enzyme 
characterization, purification, immunization, structural analysis, biomarker discovery, 
pilot studies for large scale method development, etc. Plasma fractionation for deep 
proteomic analysis is discussed in details in section 4. Similar to that of listed under 
section 3.1., ion exchange chromatography is a frequently used tool in the laboratories. 
Hemophilia A and von Willebrand’s disease are inherited bleeding disorders caused by 
the deficiencies of factor VIII and von Willebrand factor, respectively. FVIII/VWF 
concentrates are used in the therapy of the two diseases [20] but also FVIII alone can be 
given to hemophiliac patients to restore hemostasis [21]. These two glycoproteins were 
isolated by the combination of ammonium sulfate precipitation and anion exchange 
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chromatography and after the two separation steps a fraction containing the complex of 
the two proteins was obtained in which the stability of FVIII was assured by the high 
VWF content [22]. The FVIII/VWF complex can be dissociated by the addition of 
calcium, however the anion exchange chromatography after the addition of calcium was 
not successful before Josic et al. introduced a second anion exchange step to divide the 
two coagulation factors from each other. The FVIII was stabilized by its isolation with 
albumin. Another method was recently developed for the purification of coagulation 
factor VIII in which first a direct plasma anion exchange chromatography step was 
applied resulting in a fraction containing factor VIII with co-elution of vitamin K 
dependent factors, factors IX and X, which proteins were later separated by size 
exclusion chromatography from the factor VIII fraction [23].  
Heparin affinity chromatography is another widespread method for the isolation of 
plasma proteins usually combined with anion exchange chromatography as Josic et al. 
described for the purification of antithrombin III, factor IX and factor X [24]. Hoffer et 
al. combined adsorption chromatography, hydrophobic interaction chromatography and 
heparin affinity chromatography for the isolation with high purity and specific activity 
of factor IX [25]. The advent of high performance liquid chromatography (HPLC) 
offered another possibility to isolate plasma proteins. Vitamin D binding protein was 
isolated from human plasma both by HPLC and low pressure chromatographic methods. 
Using high performance liquid chromatography much higher purity and yield were 
obtained than by traditional methods in significantly shorter processing time [26]. High 
performance affinity chromatography was developed for the purification of proteins in 
an efficient manner utilizing the high specificity of the affinity matrix and the fast and 
high resolution HPLC technique [27].  
 
4 Plasma fractionation for proteomics  
Deep proteomic profiling of biological samples can lead to a vast amount of information 
that can be utilized for the description of biological processes, molecules or the 
characterization of diseases, e.g. through the identification of disease specific markers. 
In biomarker discovery proteomic methods complement the ones employed by 
genomics [28]. With the advent of modern tandem mass spectrometry (MS/MS) 
instrumentation, proteins can be studied rapidly, precisely with high sensitivity and 
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reproducibility [29]. The so called ‘top-down’ MS-based proteomics approach works at 
the protein level, while the ‘bottom-up’ method analyzes peptides derived from proteins 
after proteolytic digestion. While the latter technique is more widespread the former is 
getting more and more popular [30]. A third approach if this kind is referred to as a 
‘middle-down’ technique, offering the benefits of both the ‘top-down’ and ‘bottom-up’ 
methods. Proteins are digested with enzymes (e.g. endoproteinase Lys-C, OmpT outer 
membrane protease) cutting the proteins less frequently than trypsin, thus producing 
longer peptides that allows comprehensive characterization of large proteins along with 
their posttranslational modifications [31, 32]. These three approaches are compared in 
Figure 1. 
 
 
 
Figure 1. Scheme of the ‘top-down’, ‘middle-down’ and ‘bottom-up’ proteomic 
approaches. 
 
Comprehensive analysis of plasma proteins is a challenging task due to the high 
complexity and large dynamic range of the plasma components, thus appropriate sample 
preparation, such as pre-fractionation is highly advised  before the deeper exploration of 
its proteome for biomarker discovery [33]. The usual workflow of sample preparation 
for MS or MS/MS-based proteomics analysis starts with the depletion of high 
abundance proteins that can interfere with the detection of the lower abundant ones. 
This step also decreases the dynamic concentration range of plasma proteins, enriches 
the subproteome of interest and provides pre-fractionation before deeper analysis [34]. 
Application of three or more methods of fractionation definitely increases the 
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accessibility of lower abundance plasma proteins and the use of different pre-
fractionation/separation techniques can significantly raise the number of discoverable 
proteins. Such separation techniques include two-dimensional gel electrophoresis (2D-
GE) that separates proteins first by their isoelectric point (pI) then by molecular mass 
(MW), although having limitations for the analyses of proteins with extreme pI values 
and/or MWs (higher than 150 or lower than 10 kDa). This technique usually results in 
up to hundreds or a few thousands of protein spots that can be excised and analyzed 
downstream by mass spectrometry methods. Multi-dimensional liquid chromatography 
(MDLC) is another effective technique for global plasma protein fractionation prior to 
MS analysis [35, 36]. Besides MDLC, affinity based separation methods are also 
widespread, mainly for the removal of the most abundant plasma components. Usually 
multi-dimensional liquid chromatography and the affinity based separation are 
combined during sample preparation for MS-based proteomic analyses.  
 
4.1 Affinity-based depletion of the high abundant plasma proteins 
In proteomics a great variety of methods have been developed for the removal of the 
most abundant plasma components before downstream processing or analysis. While in 
industrial scale plasma fractionation albumin is one of the main products, in plasma 
proteomics it has to be removed to enhance the detection of lower abundant proteins. 
Travis et al. discovered that Sepharose bead conjugated Cibacron Blue (a chlorotriazine 
dye) bound albumin with high affinity [37]. This traditional depletion method, also 
called as Blue Sepharose chromatography became a widespread separation technique in 
analytical scale because it can be performed in relatively low cost. However, problems 
with non-specific binding were discovered, i.e., the dye not only bound HSA but other, 
non-albumin-type proteins [38, 39]. Immunoaffinity columns containing immobilized 
monoclonal anti-albumin antibodies [40] or affibodies [41] are also broadly used to 
partition this most abundant plasma constituent with very high specificity. Several types 
of columns containing IgGs from different mammalian species (goat, mouse, rabbit, 
etc.) are commercially available [42]. Hinerfeld et al. reported that chicken anti-human 
HSA immunoglobulin Y (IgY) antibodies - bound to hydrazide beads - featured high 
affinity towards human albumin, thus provided highly specific depletion [43]. Akgöl et 
al. [44] synthesized porous polymeric beads by suspension polymerization of 2-
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hydroxyethyl methacrylate (HEMA) and ethylene glycol dimethacrylate (EGDMA). 
The dye Reactive Red 120 was attached to these poly(HEMA-EGDMA) beads to 
adsorb HSA from human plasma with high specificity, offering an alternative method 
for albumin removal. 
 
The second most abundant constituents of the human plasma are the immunoglobulins. 
One of the most frequently used immunoglobulin isolation techniques is thiophilic 
adsorption based, introduced by Porath et al. [45]. The method was based on the general 
affinity of immunoglobulins to a ligand carrying a sulphone group in the immediate 
vicinity of a thioether group. Utilizing this phenomenon an adsorbent was synthesized 
comprising of a thioether sulphur and a neighboring sulphone group. This so-called ‘T-
gel’ readily adsorbed immunoglobulin G, M and A from human serum. Their studies 
also revealed that under optimized conditions the process was capable of preserving the 
native structure and biological activity of the immunoglobulins [46]. The method was 
recently applied for deep plasma fractionation [47]. An interesting application was 
reported by Coffinier et al. who immobilized a thiophilic ligand on ethylene-vinyl 
alcohol copolymer based hollow fiber membranes to  remove immunoglobulin G from 
human plasma [48]. Specific bacterial cell wall proteins, like protein A from 
Staphylococcus aureus [49], protein G from streptococci [50] and protein L from 
Peptostreptococcus magnus [51] are known to specifically bind various subsets of 
immunoglobulins [52]. Since the isolation of these bacterial proteins can be expensive, 
alternative lower cost solutions were explored. By the help of combinatorial chemistry, 
stable mimetic ligands were produced mimicking the function of protein A, opening up 
the possibility to generate synthetic affinity ligands for immunoglobulin  depletion in a 
more cost-effective way [53]. Sulfamethazine (SMZ) was immobilized on poly(glycidyl 
methacrylate) (PGMA) beads with bisoxirane spacer to yield an affinity medium that 
could provided an effective tool for the  depletion of immunoglobulin G from plasma  
[54]. New specific-affinity beads with metal chelate ligands and synthetic polymer bead 
matrices were synthesized by Özkara et al. [55] to isolate immunoglobulins from human 
plasma. Metal-chelated spherical poly(hydroxyethyl methacrylate) (PHEMA) beads 
were prepared by suspension polymerization and  (L)-histidine metal-complexing ligand 
was immobilized on the gel beads by covalent binding. Zn(II), Ni(II), Co(II), and Cu(II) 
12 
 
were chelated on the gel beads.  Application of these metal chelate based affinity gel 
beads could offer the possibility to deplete IgG  from human plasma in one step. 
 
Affinity-based pre-fractionation of plasma components prior to MS or MS/MS-analysis 
is an important sample preparation tool since it reduces the complexity of the plasma 
sample, enriches proteins of interest while enhancing the throughput by generating 
fewer fractions than other pre-fractionation methods [56]. The application of the so-
called multiple affinity removal system (MARS) was an important step towards the 
improved detection of low abundant proteins, compared to the depletion of albumin 
and/or the immunoglobulins only. Consequently, modern depletion methods are based 
on this multi-immunoaffinity depletion approach to remove high abundant plasma 
components using either antibody or affibody based stationary phases. Tu et al. used 
IEF-LC-MS/MS to compare the affectivity of various commercially available 
immunoaffinity columns for the depletion of 7 and 14 most abundant plasma proteins. 
For example, the multiple affinity removal system for the depletion of 14 high abundant 
plasma components deplete the following proteins: HSA, transferrin, haptoglobin, IgG, 
IgA, alpha-1-antitrypsin, fibrinogen, alpha-2-macroglobulin, alpha-1-acid glycoprotein, 
complement component C3, IgM, apolipoprotein A1, apolipoprotein A2 and 
transthyretin [57]. After the immunodepletion step, 25% more proteins were identified 
than in the untreated plasma sample [58].  
 
The combination of immunodepletion with reversed-phase liquid chromatography also 
allowed identification of low abundance. A study showed that the depletion of the six 
most abundant plasma components with antibody containing spin column removed 
about 85% of the total amount of the plasma proteins and enhanced the detectability of 
the low abundance proteins for 2-D gel electrophoretic analysis [59]. An IgY microbead 
based depletion system was reportedly efficient for the depletion of 12 abundant 
proteins - albumin, IgG, transferrin, alpha-1-antitrypsin, IgA, IgM, alpha-2-
macroglobulin, haptoglobin, apolipoprotein A1, apolipoprotein A2, alpha-1-acid 
glycoprotein, and fibrinogen - from plasma. One of the most important advantage of 
using avian IgY antibodies was that they cross-reacted with heterologous human 
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proteins to a significantly lesser extent than mammalian ones decreasing the number of 
nonspecific interactions [60]. 
 
Another new development in the field is the so-called “ProteoMiner” method that is 
utilizing a hexapeptide based a combinatorial peptide ligand library with a high variety 
of sequences. This approach is reportedly capable to equalize low and high abundant 
plasma protein concentrations. The mode of action of the library is based on solid phase 
affinity adsorption. The process  reportedly captures almost all plasma proteins at more 
or less the same level and therefore equalizes their concentration therefore significantly 
decreases the wide dynamic concentration range of plasma proteins for qualitative 
analysis [61]. Similar normalization technique was recently reported by means of 
monoclonal antibody technology by Takács and coworkers [62]. 
 
Subproteomes, such as the glycoproteome, are distinct groups of proteins within the 
plasma proteome and affinity based methods are frequently used for partitioning these 
categories [63]. Technologies were developed for glycoproteome analysis based on 
lectin and pseudo-lectin affinity fractionation [64, 65]. Multi-lectin affinity 
chromatography (M-LAC) is a recently developed approach for the fractionation of the 
human plasma glycoproteome that utilizes a combination of different lectins in one 
column. M-LAC was combined with a multi affinity removal system immunodepletion 
column to deplete the most abundant - mainly glycosylated plasma proteins [66] and the 
automated platform (High Performance Multi-Lectin Affinity Chromatography, HP-M-
LAC) was elaborated comprising targeted depletion with fractionation of the 
glycoproteome. The workflow consisted of depletion with anti-albumin antibody 
column and the M-LAC column of concanavalin A, jacalin, and wheat germ agglutinin. 
The platform proved to be stable, highly glycan specific and reproducible providing 
high recoveries for plasma proteome fractionation [67]. Combining boronic acid (a 
pseudo lectin) chromatography with lectin affinity chromatography, dubbed as BLAC, 
were applied to isolate glycoproteins by using both selective and/or combined elution 
conditions [68]. Boronic acid and concanavalin A (BLAC/Con A) resin-filled 
micropipette tips were also developed as an automated affinity micropartitioning tool to 
isolate and enrich various classes of glycoproteins from human serum/plasma for 
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downstream processing like N-linked glycan profiling [69]. The scheme of boronic acid 
lectin affinity chromatography is depicted in Figure 2. 
 
 
 
Figure 2. Schematics of boronic acid lectin affinity chromatography (BLAC). 
 
4.2 Non-affinity-based depletion methods  
Alternative methods for affinity based albumin and IgG removal are continuously being 
developed. One of the simple ones was a short monolithic column utilizing anion-
exchange chromatography [70]. Multistep processes include the above described salting 
out method (section 2.1) to first precipitate the immunoglobulins from human plasma (4 
M ammonium sulfate) followed by fractionating with anion exchange chromatography 
using diethylaminoethyl (DEAE)-cellulose column to acquire pure IgG [71]. Mahn et 
al. studied the depletion of the highly abundant plasma proteins with ammonium sulfate 
(AS) precipitation followed by hydrophobic interaction chromatography (HIC) for 
proteomics analysis. They found that the combination of the two methods had the 
potential to remove the highly abundant proteins from plasma, in particular albumin, 
immunoglobulins, alpha-1-antitrypsin, haptoglobin, and fibrinogen. Because of the 
simplicity and cost-effectiveness of this process, it could be a good alternative to 
antibody based methods [72, 73]. Brgles et al. utilized the principles of displacement 
15 
 
chromatography for plasma fractionation and the isolation of low abundance proteins. 
They applied monolithic ion exchange columns under overloading conditions with the 
consideration that HSA, IgG and other weakly bound plasma proteins were displaced by 
stronger binding ones in anion and cation exchange modes [74]. 
 
4.3 Multi-step plasma proteome fractionation  
A 783-fraction containing human plasma proteome library was generated by Kovács et 
al. - referred to as the Analyte Library - by applying a carefully designed workflow with 
the aim to use the Library for monoclonal antibody proteomics-based antigen 
identification [47]. First, 500 mL normal pooled human plasma was subject to Blue 
Sepharose affinity chromatography for HSA depletion followed by the removal of 
immunoglobulins from the albumin-depleted flowthrough by thiophilic interaction 
chromatography. Then, a pre-fractionation step of ammonium sulfate precipitation with 
increasing salt saturations of 35, 45, 65 and 75% was applied. The precipitates were 
dissolved and consecutively separated by size exclusion, cation and anion exchange 
chromatography steps. The 20 most concentrated ion exchange chromatography 
fractions were subject to hydrophobic interaction chromatography. Preservation of the 
native forms of the intact plasma proteins was top priority throughout the fractionation 
process. The scheme of the Library generation protocol is delineated in Figure 3. The 
Library fractions proved to be applicable for mAb proteomics-based antigen 
identification [75].  
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Figure 3. Flowchart of the Analyte Library generation process. 
 
Another large scale fractionation process employed strong cation exchange 
chromatography as the first dimension followed by reversed-phase HPLC as second 
dimension to pre-fractionate the human plasma proteome prior to linear ion trap MS 
analysis [76]. 1292 proteins were identified, several of them below 10 ng/mL (published 
physiological concentration). Another liquid-based fractionation system utilized ion 
exchange chromatography followed by reversed-phase chromatography [77, 78]. This 
platform was able to reveal post-translational modifications (PTMs) as well as to profile 
basic and hydrophobic proteins. For the time being, Liu et al. generated one of the most 
extensive proteome maps of the human plasma using a multidimensional approach by 
combining cation exchange chromatography, reversed-phase liquid chromatography, 
ion-mobility spectrometry, and mass spectrometry (SCX-LC-IMS-MS). Their analysis 
of 37,842 unique peptide sequences lead to 9087 unique protein entries, 2928 of which 
met their criteria of high-confidence assignments anticipated to be reproducibly detected 
with their approach. [79]. A high-resolution three-dimensional intact-protein-based 
quantitative analysis system (the IPAS) was developed by Wang et al. [80]. By using 
their profiling approach, proteomic changes in allogeneic bone marrow transplantation 
(BMT) acute graft-versus-host disease (GVHD) were detected and identified. The 
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workflow of immunodepletion, isoelectric focusing, reversed-phase liquid 
chromatography and SDS-PAGE analysis was applied for the separation of plasma 
proteins prior to mass spectrometry resulting in uncovering a broader range of 
proteomic changes than with two-dimensional gel electrophoresis. Moritz et al. 
combined continuous free-flow electrophoresis (first dimension) and reversed-phase 
HPLC (second dimension) creating a proteomics separation tool and found that in 
comparison with the gel-based fractionation methods this technique can be applied for 
the separation of either high molecular weight proteins or small peptides [28]. 
 
4.4 Other techniques 
Four precipitation methods were studied by Jiang et al. prior to deeper proteomic 
analysis comparing trichloroacetic acid (TCA), acetone, chloroform/methanol, and 
ammonium sulfate. TCA and acetone precipitation proved to be more efficient in terms 
of sample concentration and desalting for a proteomic analysis than 
chloroform/methanol or ammonium sulfate although the latter two yielded better protein 
recoveries [81].  
 
5 Concluding Remarks and Future Prospective 
In this paper we reviewed the large variety of the methods developed to fractionate 
human plasma both in industrial and laboratory scales. Besides the traditional and most 
widely used methods of salting out, precipitation, and chromatography, novel 
approaches such as affinity- and non-affinity-based depletion of the high abundant 
plasma proteins and multi-step/multi-dimensional proteome fractionation methods were 
discussed. Large/industrial scale techniques were described as they usually aim the 
purification of plasma proteins for medicinal purposes, while laboratory scale 
approaches were associated with a wider range of scientific applications, among them 
one is proteomic analysis which was demonstrated in a more detailed way. These 
techniques require continuous improvement to further fractionate this important 
biological fluid more effectively towards the manufacturing of new therapeutic products 
and the identification of novel biomarkers. The ideal method would first include a 
highly specific depletion step without the occurrence of co-depletion (which has to be 
taken into consideration in the case of e.g. Blue Sepharose chromatography). The more 
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specific monoclonal antibody based techniques are usually expensive and cannot be 
used in the case of larger plasma volumes that are frequently needed for the production 
of adequate amount of analyte. Certain multi-step methods dealing with larger volumes 
could generate the needed amounts although they sometimes are consumptive thus their 
automation could help to decrease their labor intensities, but the conditions are not 
available in every labs. Separation of the proteins in the widest possible molecular 
weight range (unlike e.g. two-dimensional gelelectrophoresis) would also be favorable. 
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